X-Linked hypophosphatemia. Data from a Spanish adult population cohort
Journal of Nephrology · 2024
DOI: 10.1007/s40620-024-01962-3 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Nephrology, 2024. Verfasst von Luis Carlos López-Romero und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Consorci Hospital General Universitari de València, Av. de Les Tres Creus, 2, 46014, València, Spain. luiscarloslopezromero…. Hauptthemen laut MEDLINE: Fibroblast Growth Factor-23, Familial Hypophosphatemic Rickets, Fibroblast Growth Factors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Kyowa Kirin Farmacéutica.
Abstract (Originalsprache)
BACKGROUND: X-linked hypophosphatemia (XLH) represents the most prevalent cause of hereditary hypophosphatemia. X-linked hypophosphatemia causes an elevation of fibroblast growth factor 23 (FGF23), a hormone responsible for inducing hyperphosphaturia, and reduced active vitamin D synthesis. Challenges in diagnosis and the absence of well-defined clinical guidelines have resulted in higher rates of late diagnoses. While numerous reports focus on pediatric X-linked hypophosphatemia patients, studies in adults are limited. METHODS: Multicenter, cross-sectional, observational study of a cohort of adult patients diagnosed with X-linked hypophosphatemia. The study identified demographic, clinical, genetic, laboratory variables, treatments used, comorbidities, and complications. RESULTS: Twenty patients diagnosed with X-linked hypophosphatemia were collected. The median age at diagnosis was 11 (1-56) years and at data collection was 44 (21-68) years. Fifty percent of cases were diagnosed in adulthood. Main clinical manifestation was osteoarticular pain, in 75% of cases, and no relation to age at diagnosis, height, phosphorus, or parathyroid hormone (PTH) levels was observed (p > 0.05). Lower limb deformities were associated with reduced stature and earlier diagnosis (p 0.05). DISCUSSION: This is the largest study on adult patients with X-linked hypophosphatemia in southern Europe. It may offer valuable insights into the natural progression and course of the condition in adults, which can aid in better clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Consorci Hospital General Universitari de València, Av. de Les Tres Creus, 2, 46014, València, Spain. luiscarloslopezromero@gmail.com.
- Department of Nephrology and Renal Transplantation, Hospital Clínic of Barcelona, Barcelona, Spain.
- Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), Nephrology Clinical Management Unit, Reina Sofia University Hospital, University of Cordoba, Córdoba, Spain.
- Department of Nephrology, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
ORCID-Profile: Luis Carlos López-Romero
Förderung
- Kyowa Kirin Farmacéutica
Zitieren
APA
López-Romero, L. C., Broseta, J. J., Muñoz-Castañeda, J. R., & Hernández-Jaras, J. (2024). X-Linked hypophosphatemia. Data from a Spanish adult population cohort. Journal of Nephrology. https://doi.org/10.1007/s40620-024-01962-3
Vancouver
López-Romero LC, Broseta JJ, Muñoz-Castañeda JR, Hernández-Jaras J. X-Linked hypophosphatemia. Data from a Spanish adult population cohort. Journal of Nephrology. 2024. doi:10.1007/s40620-024-01962-3
BibTeX
@article{LpezRomero2024,
author = {López-Romero, Luis Carlos and Broseta, José Jesús and Muñoz-Castañeda, Juan R and Hernández-Jaras, Julio},
title = {X-Linked hypophosphatemia. Data from a Spanish adult population cohort},
journal = {Journal of Nephrology},
year = {2024},
doi = {10.1007/s40620-024-01962-3}
}
EUVIMED